Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material

The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation

(2014) Mahul B. Amin et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Prevention and early detection of prostate cancer

(2014) Jack Cuzick et al.   LANCET ONCOLOGY

A Multiplex Two-Color Real-Time PCR Method for Quality-Controlled Molecular Diagnostic Testing of FFPE Samples

(2014) Jiyoun Yeo et al.   PLoS One

Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells

(2014) Zhuochun Peng et al.   PLoS One

An expression signature at diagnosis to estimate prostate cancer patients’ overall survival

(2014) Z Peng et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Prognostic Factors for Newly Diagnosed Prostate Cancer and Their Role in Treatment Selection

(2013) Juanita Crook et al.   SEMINARS IN RADIATION ONCOLOGY

The Role of Genetic Markers in the Management of Prostate Cancer

(2012) Atish D. Choudhury et al.   EUROPEAN UROLOGY

k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction

(2010) R M Parry et al.   PHARMACOGENOMICS JOURNAL